IP Library › Assignment 006268/0881
Patent Assignment
Reel/Frame 006268/0881

Change of Name Effective on 03/06/1992

Recorded: 1992-09-25 Pages: 16
Assignor
CETUS CORPORATION
Executed: 1992-03-04
Assignee
Covered Properties (210)
Preparation of Epoxides and Glycols from Gaseous Alkenes
Patent: 4,284,723 →
Application: 06/039,337 →
Method for Producing Epoxides and Glycols from Alkenes
Patent: 4,247,641 →
Application: 06/042,219 →
Method for Producing Iodine
Patent: 4,282,324 →
Application: 06/051,847 →
Process for the Production of Fructose
Patent: 4,246,347 →
Application: 06/088,103 →
Method for Single Nucleotide Alteration
Patent: 4,351,901 →
Application: 06/133,150 →
Production of 2-Keto-D-Gluconic Acid and Hydrogen Peroxide
Patent: 4,351,902 →
Application: 06/160,122 →
Manufacture of Halogenated Ketones and Aldehydes
Patent: 4,546,080 →
Application: 06/229,554 →
Process for the Production of D-Glucosone
Patent: 4,423,149 →
Application: 06/311,505 →
Method for Producing Vicinal Dihalogented Products
Patent: 4,426,449 →
Application: 06/330,157 →
Chimeric Plasmids That Replicate in Bacteria and Yeast and Microorganisms Transformed Therewith
Patent: 4,477,571 →
Application: 06/346,258 →
Bacterial Production of Heterologous Polypeptides Under the Control of a Repressible Promoter-Operator
Patent: 4,499,188 →
Application: 06/375,098 →
Biologically Active Substances, Their Obtainment from Human Casein and Compositions Containing Said Substances
Patent: 4,462,990 →
Application: 06/385,645 →
Method of Producing Long Chain Wax Esters from Ethanol
Patent: 4,567,144 →
Application: 06/408,254 →
Interferon-Alpha 54
Patent: 4,975,276 →
Application: 06/414,051 →
Interferon-Alpha 76
Patent: 5,098,703 →
Application: 06/414,053 →
Interferon-Alpha 61
Patent: 4,973,479 →
Application: 06/414,054 →
Method and Vector Organism for Controlled Accumulation of Cloned Heterologous Gene Products in Bacillus Subtilis
Patent: 4,711,843 →
Application: 06/461,248 →
Stable High Copy Number Plasmids
Patent: 4,631,257 →
Application: 06/467,369 →
Method for Using an Amino-Terminus Dna Sequence to Synthesize a Specific Double-Stranded Dna
Patent: 4,555,486 →
Application: 06/468,805 →
Stable Haloperoxidase Method
Patent: 4,707,446 →
Application: 06/497,654 →
Fungal Chloroperoxidase Method
Patent: 4,707,447 →
Application: 06/497,658 →
Monoclonal Antibody Having Specificity for the Double-Stranded Conformation of Native Dna and Diagnostic Methods Using Same
Patent: 4,623,627 →
Application: 06/524,596 →
Human Recombinant Interleukin-2 Muteins
Patent: 4,518,584 →
Application: 06/564,224 →
Method for Producing Aldehydes from Primary Alcohols
Patent: 4,503,153 →
Application: 06/570,790 →
Recombinant Diphtheria Toxin Fragments
Patent: 4,830,962 →
Application: 06/578,122 →
Assay Kit and Method for the Determination of Antibody Class and Subclass
Patent: 4,727,037 →
Application: 06/580,519 →
P. Obtusus Pyranose-2-Oxidase Preparation
Patent: 4,569,913 →
Application: 06/583,142 →
Methods and Reagents for Pyranosone Production
Patent: 4,569,910 →
Application: 06/583,143 →
Fungal Pyranose-2-Oxidase Preparations
Patent: 4,568,645 →
Application: 06/583,152 →
P. Obtusus Strain
Patent: 4,569,915 →
Application: 06/583,166 →
Process for Recovering Microbially Produced Interleukin-2 and Purified Recombinant Interleukin-2 Composition
Patent: 4,569,790 →
Application: 06/594,223 →
Method of Improving the Yield of Heterologous Protein Produced by Cultivating Recombinant Bacteria
Patent: 4,656,132 →
Application: 06/594,250 →
Human Lymphoblastoid Cell Line and Hybridomas Derived Therefrom
Patent: 4,624,921 →
Application: 06/604,068 →
Vicinal Heterogeneous Dihalogenated Products and Method
Patent: 4,587,217 →
Application: 06/607,723 →
Feline Leukemia Virus Vaccine Plasmids for Fusion Protein of the GP70 Envelop Protein of Felv
Patent: 4,701,416 →
Application: 06/612,003 →
Site Directed Peptidase Cleavage
Patent: 4,732,852 →
Application: 06/642,755 →
3'EXPRESSION Enhancing Fragments and Method
Patent: 4,792,523 →
Application: 06/646,584 →
Polypeptide Expression Using a Portable Temperature Sensitive Control Cassette with a Positive Retroregulatory Element
Patent: 4,666,848 →
Application: 06/646,709 →
Toxin Conjugates
Patent: 4,894,443 →
Application: 06/648,759 →
Stabilization of Enzymes Useful in the Production of Glucosone and Other Enzymatic Processes
Patent: 4,650,758 →
Application: 06/653,736 →
Human Recombinant Cysteine Depleted Interfuron -B Nuteins
Patent: 4,588,585 →
Application: 06/655,897 →
Method of Eliminating Canine Cauda Equina Syndrome
Patent: 4,612,918 →
Application: 06/661,351 →
Peptide Antibodies and Their Use in Detecting Oncogene Products
Patent: 4,762,706 →
Application: 06/661,686 →
Controlled Oxidation of Microbially Produced Cysteine-Containing Proteins
Patent: 4,530,787 →
Application: 06/661,902 →
Peptide Antibodies and Their Use in Detecting Oncogene Products
Patent: 4,798,787 →
Application: 06/661,909 →
Method for Promoting Disulfide Bond Formation in Recombinant Proteins
Patent: 4,572,798 →
Application: 06/679,121 →
Structural Genes, Plasmids and Transformed Cells for Producing Cysteine Depleted Muteins of Biologically Active Proteins
Patent: 4,853,332 →
Application: 06/684,483 →
Portable Temperature-Sensitive Control Cassette
Patent: 4,711,845 →
Application: 06/685,312 →
Monoclonal Anti-Human Breast Cancer Antibodies
Patent: 4,753,894 →
Application: 06/690,750 →
Cysteine-Depleted Muteins of Biologically Active Proteins
Patent: 4,959,314 →
Application: 06/698,939 →
Pharmaceutical Compositions of Microbially Produced Interleukin-2
Patent: 4,604,377 →
Application: 06/715,152 →
Recombinant Ricin Toxin Fragments
Application: 06/717,319 →
3'-Expression Enhancing Fragments and Method
Patent: 4,910,141 →
Application: 06/717,331 →
Pseudomonas Aeruginosa Exotoxin a Antibodies, Their Preparation and Use
Patent: 4,677,070 →
Application: 06/727,514 →
Pseudomonas Aeruginosa Type-Specific Human Monoclonal Antibodies, Their Preparation and Use
Patent: 1,198 →
Application: 06/727,515 →
Pseudomonas Aeruginosa Type-Specific Murine Monoclonal Antibodies, Their Preparation and Use
Patent: 494 →
Application: 06/727,516 →
Human Tumor Necrosis Factor
Patent: 4,677,064 →
Application: 06/730,696 →
Structural Genes,Plasmids and Transformed Cells for Producing Depleted Muteins of Interferon-B
Patent: 4,737,462 →
Application: 06/753,717 →
Human Tumor Necrosis Factor
Patent: 4,677,063 →
Application: 06/760,661 →
Formulation for Lipophilic Il-2 Proteins
Patent: 4,992,271 →
Application: 06/775,751 →
Process for Making T Cell Hybridomas
Patent: 4,950,598 →
Application: 06/777,947 →
Bacterial Methionine N-Terminal Peptidase
Patent: 4,870,017 →
Application: 06/778,414 →
Stable Formulation of Biologically Active Proteins for Parenteral Injection
Patent: 4,816,440 →
Application: 06/780,551 →
Method for Imaging Breast Tumors Using Labeled Monoclonal Anti-Human Breast Cancer Antibodies
Patent: 4,938,948 →
Application: 06/786,948 →
Purification Method for Tumor Necrosis Factor
Patent: 4,677,197 →
Application: 06/792,815 →
Partition Proficiency in Genetically Engineered Plasmids for Transforming Gram-Positive Organisms
Patent: 4,822,739 →
Application: 06/814,179 →
Assay for Human Breast Cancer
Patent: 4,803,169 →
Application: 06/826,477 →
Blind Label
Patent: 4,700,976 →
Application: 06/837,471 →
Recombinant Ricin Toxin
Application: 06/837,583 →
The Compound, 1-(3-(2-Pyridyldithio) Propioanmido) -12-(5- Hydrrazidoglutaramido)-4,9-Dioxadodecane
Patent: 4,797,491 →
Application: 06/840,604 →
Monoclonal Anti-Human Breast Cancer Antibodies
Application: 06/842,476 →
Method and Vector Organism for Controlled Accumulation of Heterologous Gene Products in Bacillus Subtilis
Patent: 4,816,396 →
Application: 06/843,940 →
Process for Recovering Refractile Bodies Containing Heterologous Proteins from Microbial Hosts
Patent: 4,748,234 →
Application: 06/843,997 →
Treatment of Infections with Lymphokines
Patent: 4,879,111 →
Application: 06/853,122 →
Method of Controlling Stress-Related Disease in Livestock by Administration of Human Il-2
Patent: 4,818,769 →
Application: 06/856,680 →
Bacterial Methionine N-Terminal Peptidase
Patent: 4,865,974 →
Application: 06/860,330 →
N-Terminal Derivatives of Tumor Necrosos Factor Purified by Micro- Porous Ptfe Membranes
Patent: 4,894,439 →
Application: 06/866,213 →
Human Lymphoblastoid Cell Line and Hybridomas Derived Therefrom
Patent: 4,897,466 →
Application: 06/871,529 →
Feline Leukemia Virus Vaccine
Patent: 4,789,702 →
Application: 06/873,681 →
Pharmaceutical Compositions with Galactitol as Carrier
Patent: 4,797,388 →
Application: 06/879,143 →
Solubilization of Proteins for Pharmaceutical Compositions Using Heparin Fragments
Patent: 4,745,180 →
Application: 06/879,456 →
Yxidation-Resistant Muteins
Patent: 4,752,585 →
Application: 06/893,186 →
Method of Recovering Microbially Produced Recombinant Ricin Toxin a Chain
Patent: 4,689,401 →
Application: 06/905,283 →
Recombinant Ricin Toxin a Chain Conjugates
Patent: 4,962,188 →
Application: 06/913,357 →
Human Monoclonal Antibody Against Group a Red Blood Cells
Patent: 4,764,465 →
Application: 06/913,638 →
Method of Purifying Toxin Conjugates Using Hydrophobic Interaction Chromatography
Patent: 4,771,128 →
Application: 06/917,469 →
Pharmaceutical Compositions of Lipophilic Proteins and Formulation Processes Therefor
Application: 06/923,425 →
Solubilzation of Proteins for Pharmaceutical Compositions Using Polyproline Conjugation
Patent: 4,894,226 →
Application: 06/931,197 →
Use of a Modified Soluble Pseudomonas Exotoxin a in Immunoconjugates
Patent: 4,933,288 →
Application: 06/934,248 →
Stable Formulations of Ricin Toxin a Chain and of Rta-Immunoconjugates and Stabilizer Screening Methods Therefor
Patent: 4,808,705 →
Application: 06/944,347 →
Combination Therapy Using Antitumor Immunotoxins with Tumor Necrosis Factor
Patent: 4,894,225 →
Application: 07/020,443 →
Recombinant Ricin Toxin Fragments
Patent: 5,079,163 →
Application: 07/025,262 →
Method of Improving the Yield of Heterologous Protein Produced by Cultivating Recombinant Bacteria
Patent: 4,894,334 →
Application: 07/035,069 →
Glucoamylase Cdna
Patent: 4,794,175 →
Application: 07/047,552 →
Human Cell Line and Triomas, Antibodies, and Transformants Derived Therefrom
Patent: 5,001,065 →
Application: 07/054,441 →
A Composition of Immunotoxins with Interleukin-2
Patent: 4,894,227 →
Application: 07/055,681 →
Method and Vector Organism for Controlled Accumulation of Cloned Heterologous Gene Products in Bacillus Subtilis
Patent: 4,952,508 →
Application: 07/064,841 →
Anti-Human Ovarian Cancer Immunotoxins and Methods of Use Thereof
Patent: 4,956,453 →
Application: 07/069,720 →
Anti-Human Ovarian Cancer Immunotoxins and Methods of Use Thereof
Patent: 4,958,009 →
Application: 07/069,867 →
Serum Free Media for the Growth on Insect Cells and Expression of Products Thereby
Patent: 5,024,947 →
Application: 07/077,303 →
Procaryotic Xylose Isomerase Muteins
Patent: 5,041,378 →
Application: 07/084,479 →
Certain Maleimide-N-Alkylenecarboxylate-Ortho-Nitrobenzenesulfonic Acid Esters and Derivarives Useful for Coupling Biological Materials
Patent: 4,954,637 →
Application: 07/095,325 →
Certain Pyridyl-Di-Sulfide-Alkylenecarboxylate-Ortho-Nitro- Phenylsulfonic Acid Esters Useful for Coupling Ciological Materials
Patent: 4,943,636 →
Application: 07/095,387 →
Method of Conjugating an Activated Ester to an Amine-Containing Biological Material
Patent: 5,663,306 →
Application: 07/095,396 →
Uses of Recombinant Colony Stimulating Factor-1
Patent: 5,104,650 →
Application: 07/099,872 →
Pharmaceutical Compositions of Recombinant Interleukin-2 and Formulation Processes
Patent: 5,037,644 →
Application: 07/101,175 →
A Method for Making Cereal Products Naturally Sweetened with Fructose
Patent: 4,857,339 →
Application: 07/101,561 →
A Method of Making an Enzyme Sweetened Cereal Product
Patent: 4,859,474 →
Application: 07/101,564 →
Oligonucleotide Functionalizing Reagents
Patent: 4,914,210 →
Application: 07/104,200 →
Stable Haloperoxidase Method
Patent: 4,937,191 →
Application: 07/119,825 →
Fungal Chloroperoxidase Method
Patent: 4,937,192 →
Application: 07/120,320 →
Combination Therapy Using Immunotoxins with Interleukin-2
Patent: 4,863,726 →
Application: 07/130,684 →
Ribotoxin Conjugates
Patent: 4,962,189 →
Application: 07/131,646 →
Solubilization of Immunotoxins for Pharmaceutical Compositions Using Polymer Conjugation
Patent: 4,917,888 →
Application: 07/131,901 →
Interleukin-2 Muteins and Polymer Conjugation Thereof
Patent: 5,206,344 →
Application: 07/142,467 →
Conjugation of Polymer to Colony Stimulating Factor-1
Patent: 4,847,325 →
Application: 07/146,275 →
Succinylated Interlukin-2 for Pharmaceutical Compositions
Patent: 4,931,544 →
Application: 07/148,106 →
Solubilization of Proteins for Pharmaceutical Compositions Using Polymer Conjugation
Patent: 4,766,106 →
Application: 07/148,145 →
Dna Encoding for Csf-1 and Accompanying Recombinant Systems
Patent: 4,847,201 →
Application: 07/157,094 →
Purification of Ribotoxins and Their Conjugates
Patent: 4,946,943 →
Application: 07/158,092 →
Recombinant Diphtheria Vaccines
Patent: 4,950,740 →
Application: 07/164,522 →
Process for Recovering Microbially Produced Interleukin-2
Patent: 4,931,543 →
Application: 07/167,145 →
Production of Soluble Recombinant Proteins
Patent: 4,948,729 →
Application: 07/171,132 →
Production of Purified, Biologically Active, Bacterially Produced Recombinant Human Csf-1
Patent: 4,929,700 →
Application: 07/173,428 →
Combination Therapy of Il-2 and Dtic for the Treatment of Melanoma
Patent: 4,999,339 →
Application: 07/174,000 →
Tumor Necrosis Factor Formulations
Patent: 5,215,743 →
Application: 07/181,077 →
Diagnostic Kit and Method for Rapid Detection of Antibodies
Patent: 5,077,198 →
Application: 07/181,465 →
Monoclonal Anti-Human Breast Cancer Antibodies
Patent: 5,169,774 →
Application: 07/190,778 →
Oxidation-Resistant Muteins of Il-2 and Other Protein
Patent: 5,116,943 →
Application: 07/192,293 →
SV40 Early and Rsv Promoters Useful in Saccharomyces Expression
Patent: 4,870,013 →
Application: 07/196,789 →
Vinca Alkaloid Pharmaceutical Compositions
Patent: 4,923,876 →
Application: 07/204,391 →
Compositions for Detecting Ras Gene Proteins and Cancer Therapeutics
Patent: 5,104,975 →
Application: 07/216,888 →
A Selectable Fusion Protein Having Aminoglycoside Phosphotransferase Activity
Patent: 5,116,750 →
Application: 07/223,430 →
Identification of Allele Specific Nucleic Acid Sequences by Hybridization with Crosslinkable Oligonucleotide Probes
Application: 07/225,725 →
Controlled-Release Formulations of Interleukin-2
Patent: 5,102,872 →
Application: 07/231,757 →
Human Il-2 Like Polypeptides, Dna Sequences and Recombinant Dna Molecules Therefore and Methods for the Production and Use Thereof
Patent: 4,939,093 →
Application: 07/236,296 →
Bacterial Methionine N-Terminal Peptidase
Patent: 5,013,662 →
Application: 07/255,143 →
Novel Cross-Linking Agents
Patent: 5,034,514 →
Application: 07/256,723 →
Preparation of a Polymer/Interleukin-2 Conjugate
Patent: 4,902,502 →
Application: 07/299,235 →
Method of Preparing Diphtheria Immunotoxins
Patent: 5,208,021 →
Application: 07/301,376 →
Vaccines Emplouing Strains of E.Coli Expressing Non-Indigenous Adhesins and Toxids of E.Coli
Patent: 5,137,721 →
Application: 07/307,223 →
Extraction Composition, Test Kit and Their Use to Extract or Determine Herpes Simplex Viral Antigen
Patent: 5,081,010 →
Application: 07/308,841 →
Human Il-2 as a Vaccine Adjuvant
Patent: 5,503,841 →
Application: 07/314,975 →
Immunosuppressive Analogues and Derivatives of Succinylacetone
Patent: 4,895,872 →
Application: 07/324,360 →
Pharmaceutical Composition for Interleukin-2 Containing Physiologically Compatible Stabilizers
Patent: 5,078,997 →
Application: 07/339,971 →
Multifunctional M-Csf Proteins and Genes Encoding Therefor
Application: 07/340,228 →
Stable High Copy Number Plasmids
Patent: 4,966,840 →
Application: 07/366,318 →
Combination Therapy Using Interleukin-2 and Tumor Necrosis Factor
Patent: 5,098,702 →
Application: 07/371,203 →
Method and Compositions for Solubilization and Stabilization of Polypeptides, Especially Proteins
Patent: 5,997,856 →
Application: 07/373,928 →
Human Il-2 as a Vaccine Adjuvant
Patent: 5,100,664 →
Application: 07/374,602 →
Human Recombinant Interleukin-2 Muteins
Patent: 33,653 →
Application: 07/386,207 →
Compositions for the Inhibition of Protein Hormone Formation and Uses Thereof
Application: 07/395,253 →
Cleavage Site Blocking Antibody to Prohormone Proteins and Uses Thereof
Application: 07/395,254 →
Therapeutic Combination of Free-Radical Scavenger and Tumor Necrosis Factor
Patent: 4,985,241 →
Application: 07/399,386 →
Process for Making Succinyl Acetone
Patent: 5,276,180 →
Application: 07/403,338 →
Process for Recovering Purified, Oxidized, Renatured Recombinant Interleukin-2 from Microorganisms
Patent: 5,162,507 →
Application: 07/406,365 →
Modified Signal Peptides
Patent: 4,994,379 →
Application: 07/407,701 →
Preparation of a Polymer/Interleukin-2 Conjugate
Patent: 5,089,261 →
Application: 07/415,046 →
Covalent Oligonucleotide-Horseradish Peroxidase Coujugate
Patent: 4,962,029 →
Application: 07/437,311 →
Streptomyces Promoter and Method of Use Thereof
Patent: 5,164,305 →
Application: 07/466,981 →
Quantitative Determination of a Dna Polymerase and a Test Kit Useful in Same
Patent: 5,049,490 →
Application: 07/482,137 →
Inhibitor of Cytokine Activity and Applications Thereof
Patent: 5,942,220 →
Application: 07/494,624 →
Methods and Nucleic Acid Sequences for the Expression of the Cellulose Synthase Operon
Application: 07/496,236 →
Uses of Recombinant Colony Stimulating Factor-1
Application: 07/505,256 →
Methods, Compounds, and Compositions for Immunosuppression
Patent: 5,149,688 →
Application: 07/513,983 →
In Vitro Management of Ammonia's Effect on Glycosylation of Cell Products Through Ph Control
Patent: 5,096,816 →
Application: 07/533,688 →
Combination Therapy of Il-2 and Dtic for the Treatment of Melanoma
Patent: 5,066,489 →
Application: 07/557,203 →
Methods for the Identification of Cytokine Convertase Inhibitors
Application: 07/562,720 →
Infective Drug Delivery System
Application: 07/571,017 →
Uses of Recombinant Colony Stimulating Factor-1
Application: 07/572,149 →
Peptide Medicaments for the Treatment of Disease
Application: 07/573,624 →
Conjugation of Polymer to Colony Stimulating Factor-1
Patent: 5,153,265 →
Application: 07/576,415 →
Gro Genes, Proteins, and Uses Thereof
Application: 07/590,223 →
Il-1 Receptor Antagonists Medicaments
Application: 07/594,827 →
Thioether Linked Immunotoxin Conjugates
Patent: 5,024,834 →
Application: 07/597,081 →
Bispecific Antibodies, Methods of Production, and Uses Thereof
Application: 07/605,399 →
Method for Enhancing the Anti-Tumor Therapeutic Index of Interleukin-2
Application: 07/615,964 →
Immunosuppressive Analogues and Derivatives of Succinylacetone
Patent: 5,216,005 →
Application: 07/623,095 →
Immunosuppressive Analogues and Derivatives of Succinylacetone
Patent: 5,252,603 →
Application: 07/623,096 →
Immunosuppressive Analogues and Derivatives of Succinylacetone
Patent: 5,173,482 →
Application: 07/624,078 →
Native Type Ii Gap, Methods for Purifying Various Gaps and Uses of Gaps to Diagnose Cancer
Patent: 5,830,684 →
Application: 07/624,299 →
Compositions for Identification of Papillomavirus Replication Inhibito Rs
Patent: 5,464,936 →
Application: 07/632,027 →
Novel Cross-Linking Agents
Patent: 5,276,140 →
Application: 07/639,050 →
Compositions for Detecting Ras Gene Proteins and Cancer Therapeutics
Patent: 5,234,839 →
Application: 07/672,348 →
Methods and Nucleic Acid Sequences for the Expression of the Cellulose Synthase Operon
Patent: 5,268,274 →
Application: 07/689,008 →
Method for Inhibiting Adhesion of White Blood Cells to Endothelial Cells
Patent: 5,166,133 →
Application: 07/700,526 →
Inhibitor of Nf-Kappa Beta Transcriptional Activator and Uses Thereof
Application: 07/702,770 →
Polypeptides and Antibodies Derived from 6AP Associated Protein, P62
Patent: 5,610,276 →
Application: 07/702,771 →
Process for Purifying Bacterially Produced M-Csf
Application: 07/705,399 →
Cell Culture Medium for Enhanced Cell Growth, Culture Longevity and Product Expression
Application: 07/716,959 →
Preparation of an Activated Polymer Ester for Protein Conjugation
Patent: 5,281,698 →
Application: 07/734,749 →
Combination Therapy Using Interleukin-2 and Tumor Necrosis Factor
Application: 07/743,075 →
Gap Gene Sequences
Application: 07/774,644 →
Peptide Sequences, and Diagnostic and Therapeutic Uses Thereof
Application: 07/776,878 →
Secreted Glycoprotein
Application: 07/777,121 →
Il-1 Receptor Antagonists Medicaments
Application: 07/791,474 →
Recombinant Colony Stimulating Factor-1
Application: 07/794,822 →
Process for Recovering Refractile Bodies Containing Heterologous Proteins from Microbial Hosts
Patent: 5,248,769 →
Application: 07/798,837 →
Production of Purified Biologically Active Bacterially Produced Recombinant Human Csf-1
Application: 07/799,670 →
Method for Controlling Hyperproliferative Diseases
Patent: 5,670,151 →
Application: 07/807,951 →
Methods for Adapting Cells for Increased Product Production Through Exposure to Ammonia
Patent: 5,156,964 →
Application: 07/824,694 →
Lipid Microemulsions for Culture Media
Application: 07/829,610 →
Biosynthetic Binding Protein for Cancer Marker
Application: 07/831,967 →
Infective Drug Delivery System
Application: 07/833,801 →
Coupling Agents and Sterically Hindered Disulfide Linked Conjugates Prepared Therefrom
Patent: 5,241,078 →
Application: 07/837,678 →
Human Y-Interferon Signal Peptide-Tumor Necrosis Factor(Tnf)Gene Fusions
Patent: 5,324,655 →
Application: 07/839,017 →
Method of Increasing Product Expression Through Solute Stress
Application: 07/841,906 →
Interleukin-1 Anagonist and Uses Thereof
Application: 07/877,274 →
Purified Reduced Recombinant Interleukin-2 Compositions
Patent: 5,419,899 →
Application: 07/879,753 →
Compositions for the Inhibition of Protein Hormone Formation and Uses Thereof
Application: 07/905,546 →
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Jan 29, 1981
From: NEIDLEMAN SAUL L.; GEIGERT JOHN
To: CETUS CORPORATION, A CORP. OF DEL.
Reel/Frame 003864/0935 →
Assignment of Assignors Interest. Oct 15, 1981
From: AMON, WILLIAM F. JR.; GEIGERT, JOHN; NEIDLEMAN, SAUL L.
To: CETUS CORPORATION, A CORP. OF DE.
Reel/Frame 003935/0679 →
Assignment of Assignors Interest. Dec 14, 1981
From: GEIGERT, JOHN; NEIDLEMAN, SAUL L.
To: CETUS CORPORATION
Reel/Frame 003968/0788 →
Assignment of Assignors Interest. Feb 5, 1982
From: CHANG, SHING; MEADE, JAMES H.
To: CETUS CORPORATION, A CORP. OF DE
Reel/Frame 003975/0296 →
Assignment of Assignors Interest. May 5, 1982
From: KONRAD, MICHAEL W.; MARK, DAVID F.
To: CETUS CORPORATION, 600 BANCROFT WAY, BERKELEY, CA 94710 A CORP. OF DE
Reel/Frame 004041/0912 →
Assignment of Assignors Interest. Aug 16, 1982
From: NEIDLEMAN, SAUL L.; ERVIN, JACQUELINE L.
To: CETUS CORPORATION, A CORP OF DE
Reel/Frame 004039/0202 →
Assignment of Assignors Interest. Sep 2, 1982
From: INNIS, MICHAEL A.
To: CETUS CORPORATION; 600 BANCROFT WAY, BERKELEY, CA. 94710 A CORP OF DE.
Reel/Frame 004042/0526 →
Assignment of Assignors Interest. Sep 2, 1982
From: INNIS, MICHAEL A.
To: CETUS CORPORATION; 600 BANCROFT DR. BERKELEY, CA. 94710 A CORP OF DE.
Reel/Frame 004042/0530 →
Assignment of Assignors Interest. Sep 2, 1982
From: INNIS, MICHAEL A.
To: CETUS CORPORATION; 600 BANCROFT WAY, BERKELEY, CA. 94710 A CORP OF DE.
Reel/Frame 004042/0524 →
Assignment of Assignors Interest. May 24, 1983
From: HUNTER, JENNIE C.; BELT, ANGELA; SOTOS, LYNN S.; FONDA, MICHELLE E.
To: CETUS CORPORATION, A CORP. OF DE
Reel/Frame 004134/0020 →
Assignment of Assignors Interest. May 24, 1983
From: GEIGERT, JOHN; LIU, TE-NING E.; N'TIMKULU, THABISO
To: CETUS CORPORATION
Reel/Frame 004139/0652 →
Assignment of Assignors Interest. Aug 19, 1983
From: HUANG, CHUN-MING; COHEN, STANLEY N.
To: CETUS PALO ALTO CORPORATON, A CORP. OF DE
Reel/Frame 004167/0451 →
Assignment of Assignors Interest. Feb 9, 1984
From: GELFAND, DAVID H.; GREENFIELD, LAWRENCE I.; LAWYER, FRANCES C.
To: CETUS CORPORATION, A DE CORP
Reel/Frame 004249/0936 →
Assignment of Assignors Interest. Apr 16, 1984
From: MARK, DAVID F.; LIN, LEO S.; LU, SHI-DA Y
To: CENTUS CORPORATION A CORP. OF DE
Reel/Frame 004243/0280 →
Assignment of Assignors Interest. Apr 18, 1984
From: JOLLES, PIERRE; MIGLIORE-SAMOUR, DANIELE
To: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Reel/Frame 004246/0154 →
Assignment of Assignors Interest. Aug 7, 1986
From: CETUS PALO ALTO CORPORATION A DE. CORP.
To: CETUS CORPORATION, 1400 FIFTY-THIRD STREET, EMERYVILLE, CALIFORNIA 94608, A CORP. OF DE.
Reel/Frame 004590/0839 →
Merger Oct 31, 1996
From: CETUS ONCOLOGYCORPORATION (FORMERLY CETUS CORPORATION)
To: CHIRON CORPORATION
Reel/Frame 008209/0087 →